latest update:
[TrialBase DB]

trial summary · NCT07888257

LIfestyle MEtabotype Study B (LIME-B)

Trial record from the TrialBase DB dataset, status RECRUITING, condition Nutritional and Metabolic Diseases, sponsored by German Institute of Human Nutrition. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07888257phase —enrollment 300start 2026-10-26

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Glycemic responses vary significantly among individuals, even when consuming identical foods or meals, but the factors predicting individual glucose responses to food intake remain poorly investigated. The aim of the LIfestyle MEtabotype (LIME) study is to identify lifestyle-related and mechanistic factors which predict individual postprandial glucose fluctuations in individuals with different glycemic status (prediabetes, type 2 diabetes \[T2D\] and absence of prediabetes or T2D), using comprehensive lifestyle characterization and metabolic, molecular and neurocognitive phenotyping. As part of this phenotyping, the LIME study also investigates the role of ketone bodies. Individuals with insulin resistance, prediabetes or T2D often show impaired cerebral glucose utilization. Ketone bodies, such as β-hydroxybutyrate (βHB) may serve as an alternative energy source for the brain. However, how exogenous βHB affects neurocognitive processes and decision-making in individuals with different glycemic status remains poorly understood. This record describes module B of the LIME study. Module B investigates the effects of a single dose of exogenous βHB, compared with a carbohydrate-based placebo drink, on brain structure and function, decision-making behavior and physiological and metabolic responses. Module A comprises a comprehensive lifestyle and metabolic characterization of the same participants and is registered separately as an observational study (NCT07868601). Data from both modules will be integrated in joint analyses.

Source record: https://clinicaltrials.gov/study/NCT07888257

Facts

registry idNCT07888257
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionNutritional and Metabolic Diseases
sponsorGerman Institute of Human Nutrition
sponsor classOTHER
enrollment300
start date2026-10-26
primary completion2030-12-31
completion2031-12-31
results postednot reported

Conditions

  • Nutritional and Metabolic Diseases
  • Prediabetes
  • Type 2 Diabetes

Interventions

  • βHB drink (ketone ester)
  • Carbohydrate drink

Countries

  • Germany

Intervention types: DIETARY_SUPPLEMENT

Work with this record